Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants - Wikidata - awgldk - TriplyDB

Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants

Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants

http://www.wikidata.org/entity/Q33758531

about

Glucocorticoids for acute viral bronchiolitis in infants and young children Glucocorticoids for acute viral bronchiolitis in infants and young children A small-molecule smoothened agonist prevents glucocorticoid-induced neonatal cerebellar injury Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis New means to assess neonatal inflammatory brain injury Evidence for adverse effect of perinatal glucocorticoid use on the developing brain Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.Prematurity and programming: contribution of neonatal Intensive Care Unit interventions.Infection-induced inflammation and cerebral injury in preterm infants Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome.Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit.Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants Pathogenesis, neuroimaging and management in children with cerebral palsy born preterm.Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn.Early school outcomes for extremely preterm infants with transient neurological abnormalities.Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes.Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage.Steroids and injury to the developing brain: net harm or net benefit?Antenatal Dexamethasone Exposure in Preterm Infants Is Associated with Allergic Diseases and the Mental Development Index in Children.Outcomes of small for gestational age infants born at <27 weeks' gestation.Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review An overview of risk factors for poor neurodevelopmental outcome associated with prematurity.Neural plasticity and the Kennard principle: Does it work for the preterm brain?Review of the antenatal and postnatal use of steroids.Neurological consequences of systemic inflammation in the premature neonate Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm.Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophages.Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.Exploratory study of the relationship of fat-free mass to speed of brain processing in preterm infants.Antenatal dexamethasone has no adverse effects on child physical and cognitive development: a long-term cohort follow-up investigation.Limited response to CRH stimulation tests at 2 weeks of age in preterm infants born at less than 30 weeks of gestational age.Academic achievement of adolescents born with extremely low birth weight.Neurodevelopmental impact of hydrocortisone exposure in extremely low birth weight infants: outcomes at 1 and 2 years.Constructing a relevant decision aid for parents of children with bronchopulmonary dysplasia.Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates.

P2860

Q24202303-E087A4D8-26C2-415D-87EE-C68E9D3434E5 Q24234702-4344F494-2F67-4706-B46F-562A9354BBB6 Q24607445-D372C06E-90BF-4697-B805-91DF505E1A4F Q24624543-67123124-E435-4C15-A83F-1B0A8DFE1DD8 Q26786753-83077266-BC7E-4250-B0C4-6A61234BBA33 Q26865030-CB2AB343-B7E3-47A5-B355-64162F675818 Q33442939-51189179-F815-4FB9-BB24-7053B2985E96 Q33970665-2DEBB24F-2474-4B4D-AB83-73C2B6BC3E4E Q34016458-E0DE0A74-3C5C-4D78-947F-3B98743F6922 Q34470700-DED86682-48EF-465C-883F-97E968C5BE6A Q35046594-26958EF0-ECEB-4233-9486-5D40B6D6EA78 Q35107249-5D63C95E-8BD3-4033-B1E6-FA8977A78188 Q35142112-DA971D3F-DA50-4B6C-A792-C12ED19C6938 Q35294711-03EE0E06-9F60-4E3D-ABEE-F9013D1FE2B6 Q35930615-FDF05FDD-A9F8-48DC-84C6-0543954A7C4F Q36549097-CB63A745-9604-4B49-8AF9-4B81113B712F Q36721603-8ED8E212-6017-4A05-9556-46F934DC0E0B Q37184334-D382353C-FB2A-44AE-A29E-DDF47C39F42D Q37373734-D9060BC6-8ED9-4ADF-85CD-6BA92929EFF8 Q37546455-E008E762-7E8F-4A87-B113-54E31DAD624F Q37627219-44E1D354-7465-4FD8-87FD-50FC888D3B1E Q37660418-0C585879-69F2-4E1C-8FF4-80AD4C752FD6 Q38059806-A73EF8A8-ADF5-47DF-BA80-D0E9C8F0B202 Q38111842-90F5B817-6A10-4FDB-BF72-6D50E5FCDE4D Q38200561-D1A06CF5-C95F-41F6-BD17-79424F672817 Q38648972-B8188881-4652-4CAD-BC0C-C78A47DC073D Q41058750-4D6C5C40-EC08-4116-9239-112208FA35A8 Q41491342-75825959-5D33-43B1-8B81-3223ED0AD22C Q43567453-704FD23B-9DF9-4F00-8AA2-B4A9C0CC5DA1 Q44796761-3FB1E63F-F59C-4A4A-B3D7-555FCC2608B4 Q44951183-BC4C2355-554D-4BD1-B294-C0AC1863273A Q45101881-E1BB6745-2B8B-415C-AD1B-5D40DCC08957 Q47296682-E4D62AAB-1954-4733-9E41-9ED6DE7AE15E Q47445502-A078CCC5-28F1-49D6-9D4B-0B4ABAAC9F5C Q50094670-0F9EC3DE-4975-40AF-A54E-ABC5883983AF Q50307880-486A35F7-9043-42EA-B007-6226312FEC88

P2860

Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants

http://www.wikidata.org/entity/Q33758531

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Impact of postnatal corticoste ...... emely low birth weight infants

@ast

Impact of postnatal corticoste ...... emely low birth weight infants

@en

type

label

Impact of postnatal corticoste ...... emely low birth weight infants

@ast

Impact of postnatal corticoste ...... emely low birth weight infants

@en

prefLabel

Impact of postnatal corticoste ...... emely low birth weight infants

@ast

Impact of postnatal corticoste ...... emely low birth weight infants

@en

P1433

Q33758531-1010C0EE-B217-459E-8AAC-CFED5DC09001

P1476

Q33758531-DC8DEFB2-9C8F-4971-9DD3-FB93E8777C07

P2093

Q33758531-02114456-FDB2-440E-B9CD-40564F1B8EEB

Q33758531-2EFE7A83-6EBA-406E-A583-5DA0547BCD0D

Q33758531-32751E3D-8179-4D0B-ACEA-EAD3F1D33982

Q33758531-3A29E805-753F-480B-8FD7-96557009E231

Q33758531-6F371124-B7B7-4CA6-9B7E-F35F04EA1478

Q33758531-7E746CD1-7F02-47C7-B5BD-245743398448

Q33758531-845359D1-BA87-44B6-8475-2B9D0F2A2384

Q33758531-AB7D2253-A07E-470C-ACA5-61FD40F07E56

Q33758531-B4118F76-40F7-48B8-95D5-AB3B6B235C02

Q33758531-C7CD6C6D-5E0D-45CA-8476-3F3899B93723

P2860

Q33758531-092131BC-EC53-4CBE-965B-0CABE1062658

Q33758531-0BA2DA86-3462-4C26-B903-A6F4C986AF42

Q33758531-1E8B3207-7E8D-48F4-8210-3329A6C39EEC

Q33758531-2CA1911F-13B2-4573-8E93-B8EB04045CE3

Q33758531-2E7AC37D-763D-4047-BB1F-99CC2E1F3B53

Q33758531-3AA809C8-20B5-45FB-82F1-ECB1A4DC3AAF

Q33758531-3B963228-FADE-4D0C-8108-3BA6AA14B7CD

Q33758531-3C9438E2-469F-48AD-8C0B-5F3A6678FF56

Q33758531-498A3F9F-A073-42C4-A56D-0D298081DE62

Q33758531-52D0CC61-EBE6-48A9-ABA3-74A319B29072

P304

Q33758531-21AACB22-5832-4261-B17A-4BBCD76F60D8

P31

Q33758531-12BC3964-A471-48B5-A028-621854124695

P356

Q33758531-88BC8477-CFEE-41BF-B9F3-224971913696

P407

Q33758531-1A83F286-66F5-4D89-B6BF-52192C2EC37F

P433

Q33758531-F17DF4D2-8358-4317-AA37-3820E9ADAD38

P478

Q33758531-754CFDC8-C860-449E-9005-4B53826FF7C6

P577

Q33758531-BDCFF7A0-77F3-4EF9-B0D3-AB603F6AD6E9

P5875

Q33758531-D21B863C-BFF7-4795-BA88-61A76F345E1D

P698

Q33758531-A0AA288C-4ABB-4862-9320-E418D8B50AC7

P921

Q33758531-6B5B8979-EB4F-4BF7-9C1E-6C6D7EC6A0B3

Q33758531-87587C1E-CEC7-41BB-AA65-2F4FC957CE3F

P932

Q33758531-345E3125-B679-4F60-8261-EE8B233FCA1A

P356

P1433

P1476

Impact of postnatal corticoste ...... emely low birth weight infants

@en

P2093

Abbot R Laptook

http://www.w3.org/2001/XMLSchema#string

Abhik Das

http://www.w3.org/2001/XMLSchema#string

Barbara J Stoll

http://www.w3.org/2001/XMLSchema#string

Deanne Wilson-Costello

http://www.w3.org/2001/XMLSchema#string

Eunice Kennedy Shriver Nationa ...... ment Neonatal Research Network

http://www.w3.org/2001/XMLSchema#string

John C Langer

http://www.w3.org/2001/XMLSchema#string

Krisa P Van Meurs

http://www.w3.org/2001/XMLSchema#string

Michele C Walsh

http://www.w3.org/2001/XMLSchema#string

Neil N Finer

http://www.w3.org/2001/XMLSchema#string

Ronnie Guillet

http://www.w3.org/2001/XMLSchema#string

P2860

Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants

Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs

Dexamethasone therapy increases infection in very low birth weight infants

Brain corticosteroid receptor balance in health and disease

Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants.

Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.

The International Classification of Retinopathy of Prematurity revisited.

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

P304

e430-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2008-1928

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23994479

http://www.w3.org/2001/XMLSchema#string

P698

19204058

http://www.w3.org/2001/XMLSchema#string

P921

bronchopulmonary dysplasia

P932

2846831

http://www.w3.org/2001/XMLSchema#string